PMID: 25726789Jan 1, 2014Paper

Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
A I FedinA V Fedotova

Abstract

To assess the severity of asthenic syndrome (AS) in chronic brain ischemia (CBI) in primary health care settings. The study included 1170 patients with brain ischemia, aged 45-65 years, treated with phenotropil in dose 100 mg during 2 and 3 months. Clinical examination and MFI-20 subscales were administered. RESULTS AND СONCLUSION: The high incidence of asthenic syndrome was observed across all MFI-20 subscales. The decrease in asthenic syndrome severity was significant already in the end of the first month of treatment with phenotropil. Such dynamics maintained to the end of the second and third month of treatment. More than 2-fold decrease in the severity of asthenia symptoms was achieved in all subgroups 3 months after treatment. More rapid and apparent decrease in asthenic syndrome was observed in younger patients.

References

Apr 1, 1995·Journal of Psychosomatic Research·E M SmetsJ C De Haes
May 16, 2006·Lancet·Neil C Abbot, Vance Spence
Dec 17, 2009·Population Health Metrics·Jin-Mann S LinWilliam C Reeves

❮ Previous
Next ❯

Citations

Mar 22, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A R GodunovaSh G Musin
Jul 18, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·L S Chutko, S Yu Surushkina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Related Papers

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
L S ChutkoE A Iakovenko
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
G N Bel'skaiaI N Tikhomirova
© 2022 Meta ULC. All rights reserved